23 May 2013
Keywords: fda, priority, review, sanofi, lovenox, stemi, food
Article | 12 February 2007
The Food and Drug Administration has accepted for review a supplemental New Drug Application for Sanofi-Aventis' anticoagulant Lovenox
(enoxaparin sodium ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 February 2007
22 May 2013
© 2013 thepharmaletter.com